Zero suicide implementation-effectiveness trial study protocol in outpatient behavioral health using the A-I-M suicide prevention model.

Contemporary Clinical Trials
Barbara StanleyLisa B Dixon

Abstract

The treatment of suicidal patients often suffers owing to a lack of integrated care and standardized approaches for identifying and reducing risk. The National Strategy for Suicide Prevention endorsed the Zero Suicide (ZS) model, a multi-component, system-wide approach to identify, engage, and treat suicidal patients. The ZS model is a framework for suicide prevention in healthcare systems with the aspirational goal of eliminating suicide in healthcare. While the approach is widely endorsed, it has yet to be evaluated in a systematic manner. This trial evaluates two ZS implementation strategies statewide in specialty mental health clinics. This trial is the first large-scale implementation of the ZS model in mental health clinics using the Assess, Intervene, and Monitor for Suicide Prevention (A-I-M) clinical model. Using a hybrid effectiveness-implementation type 1 design, we are testing the effectiveness of ZS implementation in 186 mental health clinics in 95 agencies in New York State. Agencies are randomly assigned to either: "Basic Implementation" (BI; a large group didactic learning collaboratives) or "Enhanced Implementation" (EI; participatory small group learning collaboratives; enhanced consultation for site champions...Continue Reading

References

Dec 1, 1981·American Journal of Epidemiology·A DonnerC Buck
Jan 1, 1993·The American Journal of Psychiatry·G M AsnisJ M Harkavy-Friedman
Jun 4, 2002·The American Journal of Psychiatry·Jason B LuomaJane L Pearson
Jun 20, 2002·Journal of Substance Abuse Treatment·Wayne E K LehmanD Dwayne Simpson
Aug 4, 2005·JAMA : the Journal of the American Medical Association·Gregory K BrownAaron T Beck
May 15, 2010·American Journal of Public Health·Kerry L KnoxEric D Caine
May 21, 2010·JAMA : the Journal of the American Medical Association·Tracy Hampton
Jun 1, 2011·Journal of Clinical Psychology in Medical Settings·Lisa A BrennerHerbert T Nagamoto
Mar 1, 2012·Administration and Policy in Mental Health·Bevin Croft, Susan L Parish
Mar 7, 2012·American Journal of Public Health·Mark A IlgenMarcia Valenstein
Feb 28, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Madhukar H TrivediA John Rush
Jun 14, 2013·The Milbank Quarterly·Erum NadeemSarah McCue Horwitz
Oct 4, 2013·Implementation Science : IS·David A ChambersKurt C Stange
Feb 26, 2014·Journal of General Internal Medicine·Brian K AhmedaniLeif I Solberg
Jun 3, 2014·Psychiatric Services : a Journal of the American Psychiatric Association·Erum NadeemSarah McCue Horwitz
Jul 16, 2015·International Journal of Epidemiology·Clare RutterfordSandra Eldridge
Jul 16, 2015·Psychiatric Services : a Journal of the American Psychiatric Association·Ian H StanleyThomas E Joiner
Mar 13, 2018·Frontiers in Psychiatry·Beth S BrodskyBarbara Stanley
Oct 3, 2019·JAMA Psychiatry·Barbara Stanley, J John Mann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.